baber/WOPTO huggingface dataset:
Patent NZ-580194-A (NZ)
Title: Novel fully human anti-vap-1 monoclonal antibodies
Inventor: SMITH DAVID
IPC: A61K39/395
Filed: 2008-04-17
Abstract: Disclosed is an anti-VAP-1 antibody or VAP-1 binding fragment thereof, comprising a heavy chain polypeptide, wherein the heavy chain polypeptide comprises, in the following order, the CDR sequences set forth as SEQ ID NOs: 1, 2, and 3, and a light chain polypeptide comprising, in the following order, the CDR sequences set forth as SEQ ID NOs: 24, 25, and 26, characterized in that it is fully human. Also disclosed is The use of the antibody for the preparation of an agent useful for treating or diagnosing a VAP-1 mediated inflammatory disorder in a patient in need thereof, wherein said VAP-1 mediated inflammatory disorder is selected from the group consisting of arthritides and connective tissue diseases, inflammatory bowel diseases, dermatoses, multiple sclerosis, inflammatory neuropathy, inflammatory myopathy, acute disseminated encephalomyelitis, vasculitis of the central nervous system, Sjögrens syndrome, diabetes, systemic lupus erythematosus, asthma, inflammatory liver disease, Graves disease and thyroiditis.
Patent NZ-581823-A (NZ)
Title: High speed and high power laser scribing system with a laser, mirror and controller
Inventor: COSTIN DARRYL J
IPC: B23K26/08
Filed: 2008-06-12
Abstract: A method of scribing a graphic on a material 42, comprises applying a laser output 38 to a material 42 to scribe a graphic on a surface of the material 42, where the laser output 38 is moved relative to the material at a speed in the range of 10 m/s to 65m/s, and the laser output has a power greater than 500 W, and changing the power of the laser output with a controller having a speed in the range of 10,000 pixels/second to 50,000 pixels/second.
Patent NZ-584876-A (NZ)
Title: Inhalation compositions comprising montelukast acid and a pde-4-inhibitor or an inhaled corticosteroid
Inventor: THIBERT ROCH
IPC: A61K31/444
Filed: 2008-10-23
Abstract: A medicinal preparation comprising montelukast acid (preferably in crystalline form) and mometasone furoate as a combined preparation for simultaneous, sequential or separate administration by inhalation is disclosed. This medicinal preparation is suitable for the treatment of respiratory disorder such as asthma.
Patent NZ-588218-A (NZ)
Title: Improved method for producing hydrogen cyanide through catalytic dehydration of gaseous formamide?direct heating
Inventor: BOEHLING RALF
IPC: B01J12/00
Filed: 2009-03-30
Abstract: Disclosed is a process for preparing hydrocyanic acid by catalytic dehydration of gaseous formamide at temperatures of from 350 to 650 degrees C in a reactor, wherein the dehydration of formamide is coupled with an exothermic reaction by the reactor comprising two separate fluid paths which are separated by a common reactor wall, with one fluid path being provided for the dehydration of formamide and the second fluid path being provided for the exothermic reaction and the common reactor wall being made of a material having a specific thermal conductivity lambda of at least 10 W/(mK), wherein the exothermic reaction is a catalytic combustion of combustible gases with introduction of oxygen.
Patent NZ-588462-A (NZ)
Title: Cyclopentylacrylic acid amide derivative
Inventor: FUKUDA YASUMICHI
IPC: A61K31/428
Filed: 2009-04-27
Abstract: Disclosed is a compound represented by the general formula (1) e.g. (E)-3-[1-alpha, 3-alpha, 4-alpha)-3,4-difluorocyclopentyl]-N-(5-fluorothiazol-2-yl)-2-(4-(methylsulfonyl)phenyl)acrylamide,or a pharmaceutically acceptable salt thereof wherein the substituents are defined in the specification for treatment or prevention of diabetes.
Patent NZ-588766-A (NZ)
Title: Sterilization wraps and methods for sterilizing articles where the wrap has a visual chemical indicator which is visible when the wrap is opened
Inventor: CANNADY CLAY
IPC: A61B19/02
Filed: 2004-10-13
Abstract: A sterilization wrap for wrapping an article to be sterilized, comprises at least one panel of sterilization material 32 and a chemical visual indicator 42 responsive to the presence of sterilant so as to indicate whether or not the article has been exposed to adequate sterilization conditions. The chemical visual indicator 42 is not visible when the article to be sterilized is wrapped with the sterilization wrap, and is only visible when the article to be sterilized is unwrapped.
Patent NZ-595838-A (NZ)
Title: Arylsulfonamide ccr3 antagonists
Inventor: FORRESTER JARED ANDREW
IPC: A61K31/495
Filed: 2010-04-21
Abstract: 595838 Disclosed are 4-(phenoxy)-3-(4-(alkanoyl)piperazin-1-ylsulfonyl)benzonitrile derivatives as represented by the general formula (I), wherein X is O or S; RYa is –C(O)R1a, –C(O)OR1a, –C(O)NR1bR1c, –C(S)NR1bR1c, –C(S)NR1aC(O)NR1bR1c, –C(NR1a)NR1bR1c, or –C(NNO2)NR1bR1c, with the proviso that RYa is neither –C(O)O-C1-6alkyl nor –C(O)H; and wherein the remaining substituents are as defined herein. Representative compounds include 4-(3,5-dimethylphenoxy)-3-(4-propionylpiperazin-1-ylsulfonyl)benzonitrile, 3-(4-(2,2-dimethylbutanoyl)piperazin-1-ylsulfonyl)-4-(3,5-dimethylphenoxy)benzonitrile, 4-(3,5-dichlorophenoxy)-3-(4-(4-(trifluoromethyl)benzoyl)piperazin-1-ylsulfonyl)benzonitrile, 4-chloro-1-(4-(2-(2,5-dichlorophenylthio)-5-nitrophenylsulfonyl)piperazin-1-yl)butan-1-one and 1-(4-(2-(2,5-dimethylphenylthio)-5-nitrophenylsulfonyl)piperazin-1-yl)-3-methylbutan-1-one. Further disclosed is a pharmaceutical composition comprising a compound as defined above, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, or tautomer thereof; one or more pharmaceutically acceptable carriers or excipients; and optionally a second therapeutic agent; for the treatment, prevention, or amelioration of one or more symptoms of a CCR3-mediated disorder, disease, or condition in a subject, such as asthma, allergic asthma, exercise induced asthma, allergic rhinitis, perennial allergic rhinitis, seasonal allergic rhinitis, atopic dermatitis, contact hypersensitivity, contact dermatitis, conjunctivitis, allergic conjunctivitis, eosinophilic bronchitis, food allergies, eosinophilic gastroenteritis, inflammatory bowel disease, ulcerative colitis, Crohn’s disease, mastocytosis, hyper IgE syndrome, systemic lupus erythematous, psoriasis, acne, multiple sclerosis, allograft rejection, reperfusion injury, chronic obstructive pulmonary disease, Churg-Strauss syndrome, sinusitis, basophilic leukemia, chronic urticaria, basophilic leukocytosis, psoriasis, eczema, COPD (chronic obstructive pulmonary disorder), arthritis, rheumatoid arthritis, psoriatic arthritis, osteoarthritis, and cardiovascular disorders.
Patent NZ-600186-A (NZ)
Title: Label ejection device
Inventor: FEFIN CHRISTIAN
IPC: B65C9/18
Filed: 2010-10-28
Abstract: 600186 A label ejection method and device (101) is disclosed comprising a removing means (106) for discarding faulty self-adhesive labels (103) from a sheet like support (104). The removing means (106) has an adhesive portion (106') operable to contact and adhere to part of the label (103). The device (101) moves the adhesive portion (106') apart from the support sheet (104) to remove and thereby discard the label (103).
Patent NZ-600640-A (NZ)
Title: Abuse-resistant formulations
Inventor: HAMED EHAB
IPC: A61K31/485
Filed: 2010-12-16
Abstract: This disclosure relates to a sustained-release oral dosage form for once-a-day administration comprising a matrix containing a viscosity modifier and coated granules containing hydromorphone. The dosage form can have a release profile such that 16 hours following administration, less than about 85 percent of the hydromorphone is released. In addition, the dosage form may have alcohol and/or crush resistance.
Patent NZ-601180-A (NZ)
Title: Combinations of biological control agents and insecticides or fungicides
Inventor: BUGG KEVIN
IPC: A01N63/00
Filed: 2009-04-07
Abstract: NZ 601180 Disclosed is a composition, and its use in treating a plant, comprising Bacillus firmus CNCM I-1582 spore and an insect control agent, wherein the insect control agent is selected from the list: clothianidin, imidacloprid, thiacloprid, thiamethoxam, acetamiprid, methiocarb, thiodicarb, beta- cyfluthrin, cyfluthrin, deltamethrin, tefluthrin, emamectin- benzoate, avermectin, spirodiclofen, spiromesifen, spirotetramat, flubendiamide, (R),(S)-3- chloro-N1-{ 2- methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl} -N2-(1-methyl- 2- methylsulphonylethyl)phthalamide, chlorantraniliprole (Rynaxypyr), or Cyantraniliprole (Cyazypyr), 4-{ [(6-chlorpyrid-3-yl)methyl](2,2-difluorethyl)amino} furan-2(5H)-on.
Patent NZ-601597-A (NZ)
Title: Water heating system with an instantaneous heating element, buffer tank and controllable pump for recirculating water from the tank
Inventor: PUSSELL PATRICK
IPC: F24D17/00
Filed: 2009-11-03
Abstract: Disclosed is a hot water system (50) comprising a water storage tank (14) and an instantaneous-type water heater (12). The storage tank (14) has an inlet (22) in fluid communication with the outlet (20) of the instantaneous-type water heater (12) and an outlet (24). The inlet (18) of the instantaneous-type water heater (12) is in fluid communication with a mains water supply (26). The water heater (12) is adapted to energise in response to a flow of water through the water heater (12). The hot water system (50) also includes a first pump (52), with an inlet (56) in fluid communication with a second outlet (54) of the tank (14) and an outlet (60) in fluid communication with the inlet (18) of the water heater (12), and a controller (42). The controller (42) is adapted to, upon user instruction, energise the first pump (52) and cause water to be directed from the outlet (20) of the water heater (14) to the inlet (22) of the tank (14) and from the second outlet (54) of the tank (14) to the inlet (18) of the water heater (12) in order to heat the water in the tank (14).
Patent NZ-602498-A (NZ)
Title: Protein formulations and methods of making same
Inventor: TSCHOEPE MARKUS
IPC: A61K38/00
Filed: 2008-11-28
Abstract: Discloses an aqueous formulation comprising an antibody and water, wherein the formulation has a conductivity of less than about 2.5 mS/cm, the concentration of the antibody is at least 30 mg/ml and the antibody has a molecular weight greater than about 47 kDa. Further discloses where the formulation comprises mannitol and polysorbate 80. Further discloses where the antibody concentration is greater than 50mg/ml Further discloses where the antibody is adalimumab, D2E7 or Humira.
Patent NZ-607405-A (NZ)
Title: Method for enzymatic saccharification treatment of lignocellulose-containing biomass, and method for producing ethanol from lignocellulose-containing biomass
Inventor: ISHIKAWA KOTARO
IPC: C12P19/14
Filed: 2011-08-31
Abstract: Disclosed is a method for the enzymatic saccharification of a lignocellulosic raw material, characterized in: adding a pretreated lignocellulosic raw material as a material suitable for an enzymatic saccharification reaction, together with an electrolyte composed of a water-soluble salt, to water that contains a cellulose saccharification enzyme; saccharifying the raw material by an enzymatic saccharification reaction, as a suspension of the raw material having an electrical conductivity adjusted to 5−25 mS/cm and; separating and recovering a reaction product and an enzyme-containing solution from the enzymatically saccharified treatment suspension; and recycling the recovered enzyme-containing solution as the enzyme for the enzymatic saccharification step.
Patent NZ-614001-A (NZ)
Title: Modified lecithin-cholesterol acyltransferase enzymes
Inventor: SCHWARZ MARGRIT
IPC: C12N9/10
Filed: 2008-07-25
Abstract: A modified lecithin-cholesterol acyltransferase (LCAT) protein comprising at least one amino acid modification as compared to a mature human LCAT amino acid sequence, the mature sequence having at least 95% sequence identity to a sequence as set forth in SEQ ID NO: 1 or SEQ ID NO: 2; and an immunoglobulin G (IgG) constant (Fc) domain, wherein the modification to the LCAT protein sequence consists of a C31Y substitution and an F1 substitution selected from the group consisting of F1A, F1G, F1I, F1L, F1M, F1P, F1V, F1C, F1Y, F1T, F1Q, F1N, F1H and F1D.
Patent NZ-614243-A (NZ)
Title: Bispecific binding molecules binding to dll4 and ang2
Inventor: GSCHWIND ANDREAS
IPC: C07K16/22
Filed: 2012-03-30
Abstract: Discloses a bispecific binding molecule comprising at least one Ang2-binding component, at least one Dll4-binding component, and - at least one serum albumin binding component, wherein said Ang2-, Dll4- and serum albumin binding components are immunoglobulin single variable domains, each immunoglobulin single variable domain consisting of four framework regions and three complementarity determining regions (CDRs), and wherein said bispecific binding molecule is selected from the group consisting of bispecific binding molecules having (i) the CDR sequences as present in DLLANGBII00017 (SEQ ID NO: 476), (ii) the CDR sequences as present in DLLANGBII00018 (SEQ ID NO: 477), and (iii) the CDR sequences as present in DLLANGBII00019 (SEQ ID NO: 478).
Patent NZ-621994-A (NZ)
Title: Transdermal venous access locking solutions
Inventor: MILLS STANLEY L
IPC: A61L29/16
Filed: 2011-08-31
Abstract: Disclosed herein are microbial growth inhibiting solutions comprising sodium caprylate, disodium ethylenediaminetetraacetic acid (EDTA) present in an amount ranging from about 0.01 mg/mL to about 2 mg mL, and citrate. Also disclosed are methods of employing the microbial growth inhibiting solutions in flushing and coating medical devices.
Patent NZ-629451-A (NZ)
Title: Extendable mechanism with locking means for use in a work machine quick hitch coupling device
Inventor: CUNNINGHAM ANDREW
IPC: E02F3/36
Filed: 2013-08-19
Abstract: Disclosed is a lockable extendible mechanism for use in a quick hitch coupling device for coupling an attachment to a mechanical arm of, for example, an excavator. The extendable mechanism is moveable through a first state and a second state. The mechanism comprises a force receiving member or threaded cylinder wherein application of a force of a first direction to the force receiving member results in the extendable mechanism moving toward the first state, and wherein application of a force of a second direction to the force receiving member results in the mechanism moving toward the second state. A locking member is in communication with the force receiving member, the locking member moveable between a locked configuration and an unlocked configuration. The mechanism when in the locked configuration, the locking member restricts movement of the extendable mechanism toward the first state. Application of the first direction of force to the force receiving member results in the locking member moving to the unlocked configuration, and application of the second direction of force to the force receiving member results in the locking member moving to the locked configuration.
Patent NZ-630443-A (NZ)
Title: A baby carrier
Inventor: GOWER CAMPBELL DOUGLAS
IPC: A47D13/02
Filed: 2014-09-08
Abstract: A multi functional baby carrier 1 comprises two strap loops 5 which are interconnected and configured to extend around shoulder or back areas of a wearer, and a main body attached to the two strap loops 5. The main body forms a seat to support a baby, and has at least two moveable side members 16 configured to adjust a width of the main body portion. The width of the main body portion is altered to a narrow position when the side members are folded back substantially inwards towards a centreline of the main body and retained in position when in a front face outward mode.
Patent NZ-701263-A (NZ)
Title: Paper, labels made therefrom and methods of making paper and labels
Inventor: VAN BOOM JOEL
IPC: B41M5/40
Filed: 2013-03-22
Abstract: Paper is disclosed for use in making repositionable or removable adhesive labels. Figure 2 illustrates a preferred construction of the paper according to the disclosure. Paper (20) is coated with top coat (21) which in turn is coating with a release layer (22). Top coat (21) may be a single or multiple layers, such as two layers. The top coat is useful on thermal paper to avoid activation of the thermal layer by handling of the paper or by the release layer. On the opposite side of the paper, a primer and/or cleaning layer (or layers) (23) is provided and on that an adhesive layer (24), preferably applied in two or more layers. Adhesive (24) is arranged in a series of discrete areas, particles or spots. These are preferably individually isolated and spaced apart. They are preferably symmetrically arranged on either side of the center line (C). Paper (20) is a light weight paper, preferably having a weight of 40 to 65 gsm. For POS printers the paper is a thermal paper having a thermally responsive treatment on the surface facing the top coat layer (21). Paper can be utilized that has a suitable top coating from the paper mill, or a suitable top coat can be applied in line.
Patent NZ-703409-A (NZ)
Title: Use of an amphoteric chelating agent for preventing contact allergies
Inventor: BLOMET JOëL
IPC: A61P17/16
Filed: 2013-07-17
Abstract: The invention relates to the use of at least one amphoteric chelating agent which comprises a complex based on aluminium and on ethylenediaminetetraacetic acid or the trisodium salt thereof, having the general formula [Al(Y)Bn]c’Dc with B being OH-, BO2 or H-,Y being a tetracarboxylate which can be protonated four times to form ethylenediaminetetraacetic acid, n being an integer equal to 0, 1, 2 or 3, D being a counterion, preferably Na+, c being an integer equal to 0, 1, 2 or 3 and c’ being a relative number having the same absolute value as c, for preventing contact allergies. It also relates to a device, a part of which comprises said amphoteric chelating agent.
Patent NZ-717731-A (NZ)
Title: Extensible media format system and methods of use
Inventor: GILBERT VINCENT LOGAN
IPC: H04L9/12
Filed: 2014-08-01
Abstract: The present invention relates to content delivery systems, and more particularly to an improved system and methods for encoding, storing, retrieving and delivering digital content using Extensible Markup Language (“XML”). Problems of prior art content delivery systems include that, as content size increases, it becomes increasingly difficult (or at least time- and bandwidth-consuming) to distribute content over the Internet, and also that content may be copied without permission or viewed by others who should not have access to the content. The present invention seeks to solve these problems by providing a computer-implemented method for managing digital content in an extensible media format, the method comprising the steps of implementing an at least one initial request server in memory on an at least one computing device, said initial request server configured for receiving and processing requests for content from an at least one client device in the possession of a user, implementing an at least one content server in memory on the at least one computing device, said content server configured for storing and selectively distributing the content, storing the content in an at least one text-based extensible media format (”EMF”) file, each EMF file comprising a frame page containing a frame page identifier, used for sequentially arranging the at least one EMF file when assembling the content on the client device, and an at least one frame, each frame containing at least a portion of the content stored in text based EMF along with a frame identifier used for sequentially arranging the at least one frame when assembling the content on the client device, and upon the initial request server receiving a content request from the user via the associated client device, transmitting to said client device each EMF file containing at least a portion of the requested content.
Patent NZ-728343-A (NZ)
Title: Apparatus and method for electrically killing plants
Inventor: DIPROSE MICHAEL FREDERIK
IPC: A01M21/04
Filed: 2015-07-27
Abstract: An electrical energy processing unit of apparatus to kill a plant or at least attenuate plant growth, the electrical energy processing unit comprising: a converter configured to receive unprocessed electrical energy from an electrical energy source, to convert the unprocessed electrical energy to processed electrical energy and to output said processed electrical energy to an applicator unit; a control circuit operable to control the converter to convert the unprocessed electrical energy to the processed electrical energy, wherein the processed electrical energy comprises a waveform with a frequency of at least 18 k Hz and with a peak voltage of at least 1 k V.
Patent NZ-732177-A (NZ)
Title: Sweeping machine for processing ground surfaces, in particular lawns
Inventor: DE BREE CORNELIUS HERMANUS MARIA
IPC: E01H1/02
Filed: 2013-11-05
Abstract: Sweeping machines for working ground surfaces are known that comprise a machine frame adapted to be moved in the traveling direction, in which machine frame at least one wheel axle with at least one wheel is supported transversely to the traveling direction, the wheel axle carrying the machine frame parallel to the ground surface. There is a need to provide sweeping machines that can be manufactured as economically and as simply as possible, which sweeping machines can be transported to the site to be swept in a transport position in which the sweeping element does not touch the ground surface, and wherein the sweeping element is driven only when it is in contact with the ground surface. The present invention provides a sweeping machine adapted to be pulled by a towing vehicle, for sweeping a ground, comprising a machine frame; at least two wheels adapted to rotate about at least one wheel axle; at least two sweeping elements are provided, one sweeping element being arranged ahead of the at least one wheel axle and one sweeping element being arranged behind the at least one wheel axle, seen in the traveling direction, wherein the sweeping elements are adapted to rotate about respective sweeping element axes, the sweeping elements being in contact with the ground, when in its operating position, and sweep the ground, the respective sweeping element axes in the operating position being coupled with the at least one wheel axle so that the sweeping elements can be driven by the rotation of the wheel axle; wherein the at least two sweeping elements are adapted to be pivoted to a transport position in which the at least two sweeping elements do not contact the ground, the at least one wheel axle and the respective sweeping element axes being decoupled from each other in the transport position so that the at least two sweeping elements are not driven in the transport position.
Patent NZ-732704-A (NZ)
Title: Quinoline carboxamides for use in the treatment of leukemia
Inventor: ERIKSSON HELENA
IPC: A61K31/4704
Filed: 2015-11-05
Abstract: A compound of formula (I) or a pharmaceutically acceptable salt thereof, for use in the treatment of leukemia.
Patent NZ-736106-A (NZ)
Title: Aquatic visual data collector
Inventor: HARVEY MATTHEW
IPC: G01C13/00
Filed: 2016-03-11
Abstract: A system for the collection of visual and related data on marine and other underwater habitats and fauna, in particular and without limitation for benthic habitats over significant spatial scales. The system can include elements such as a digital or video camera to receive visual images, various sensors to sense other related data and waterproof housings to protect various elements of the device. A sensor may for example be a global positioning system. The device can also include elements to control the device and to record, transfer & process the data.